News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ProFibrix to Present FibrocapsTM Phase II Data & Progress in Recombinant Fibrinogen Program at International Conferences


7/5/2012 10:54:59 AM

LEIDEN, The Netherlands & SEATTLE--(BUSINESS WIRE)--ProFibrix B.V., a leader in the development of innovative bioactive products to stop bleeding (hemostasis), will present the results of the company’s Fibrocaps Phase II (FC-002) trial, as well as the progress made by ProFibrix in its groundbreaking recombinant fibrinogen program at two international scientific conferences this week.

Read at BioSpace.com

comments powered by Disqus
ProFibrix
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES